Most COVID-19-related EUAs Lack Strong Supporting Evidence, JAMA Article Says

High-quality evidence was lacking for most of the COVID-19 diagnostics, medical devices and drugs the FDA has granted Emergency Use Authorization (EUA) since the start of the pandemic, claimed researchers at Israel’s Tel-Aviv University in a provocative analysis in the journal JAMA Internal Medicine.
Source: Drug Industry Daily